We propose that USP3A‐induced activation of ALKBH5 may serve as a foundation for the development of more potent glioma treatments, given the important functional significance of ALKBH5 in GBM carcinogenesis [162]. The gene discussed is ALKBH5; the disease is central nervous system cancer.